The Future Of Healthcare Smarter
Health FX is leveraging over eight years of success in healthcare facilitation and creating a distributed technology platform that provides curated and quality-optimised healthcare for everyone.
Healthcare Industry White Papers
'White Papers' is specialized section provide real, actionable information to prospects. Done well, they shorten sales cycles, educate prospects and showcase a company’s thought leadership. White papers are hosted behind a registration-based landing page that captures key lead scoring information.
White Paper publication program on healthtechglobal.com benefit from our integrated audience database. Registration can be pre-populated based on our database of professionals, providing for superior conversion rates. — If interested, Post your company's White Papers here
Global health care outlook — The evolution of smart health care
With quality, outcomes, and value the watchwords for health care in the 21st century, sector stakeholders around the globe are looking for innovative, cost-effective ways to deliver patient-centered, technology enabled “smart” health care, both inside and outside hospital walls.
Digital Healthcare Ecosystem
The healthcare industry across the globe is going through a wave of accelerated growth today. With global spending on healthcare services expected to rise by an average of 5.3 percent from 2014 – 2017, there is unprecedented pressure on everyone involved to meet ever-rising expectations.
Artificial intelligence (AI) in healthcare and research
There is no universally agreed definition of AI. The term broadly refers to computing technologies that resemble processes associated with human intelligence, such as reasoning, learning and adaptation, sensory understanding, and interaction.
Ensuring the Future of Accessible Medicines in the U.S.
Today’s generic and biosimilar medicines industry includes a range of diverse companies that have become global leaders both in providing safe and effective FDA-approved medicines and in pioneering new treatment options for patients. Generic competition continues to play a vital role in improving access to pharmaceuticals and driving cost savings to American patients and the health care system.